FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226502277> ?p ?o ?g. }

• W4226502277 endingPage "206" @default.
• W4226502277 startingPage "188" @default.
• W4226502277 abstract "Background: Nanotechnology symbolizes a broad discipline with enormous potential in cancer treatment bridging one of the bottlenecks of traditional approaches in cancer therapy which is an inability to deliver adequate quantities of anti-cancer drugs to the tumor area. Studies on nanoparticles indicate their importance in cancer angiogenesis and metastasis. Aim: The present study assessed anti-angiogenesis and anti-metastatic effects of biogenic silver nanoparticles (AgNPs) synthesized from neem plant (Azadirachta indica). Methods: Chicken chorioallantoic membrane (CAM) and two-dimensional (2D) wound healing assays were used to study anti-angiogenic and anti-metastatic effects of the AgNPs respectively. Twenty-four fertilized eggs were divided into four groups: two biogenic AgNPs treatments at 100 μg/ml and 200 μg/ml; negative control (1% DMSO) and positive control (cyclophosphamide). On day 8 of incubation, filter discs impregnated with different concentration levels of the treatments were placed on the CAM. On day 12 of incubation, the CAMs were imaged using a stereomicroscope, scaled using ImageJ, and different morphometric and spatial parameters computed using AngioTool software. Vessel area, vessel percent area, total number of junctions, total vessel length, average vessel length, mean lacunarity, and junction density were measured. The crown-rump length (CRL) and fetal weight were also recorded on day 16 of incubation. In order to determine relative gene expression profiles of iNOS and VEGF, total RNA was extracted from the CAM, and qRT-PCR was performed with β-Actin as a reference gene. For the 2D wound healing assay, DU145 human prostate cells were grown in Dulbecco’s Modified Eagle’s Medium supplemented with 10% Fetal Bovine Serum. Results: Biogenic AgNPs demonstrated anti-angiogenic effects in a dose-dependent manner in the parameters generated from the CAM images. Also, qRT-PCR revealed down-regulation of iNOS and VEGF genes. The 2-dimensional wound healing assay showed inhibition of migration and motility of the DU145 cells for the 72-hours of assessment. Conclusion: The present study postulates that the biogenic AgNPs can prevent angiogenesis by inactivation of VEGF-NO and VEGF/VEGF-R pathways while inhibiting cell migration and metastasis." @default.
• W4226502277 created "2022-05-05" @default.
• W4226502277 creator A5000715076 @default.
• W4226502277 creator A5016973739 @default.
• W4226502277 creator A5041280072 @default.
• W4226502277 creator A5050446365 @default.
• W4226502277 creator A5057461703 @default.
• W4226502277 creator A5070791069 @default.
• W4226502277 creator A5074017276 @default.
• W4226502277 creator A5082515443 @default.
• W4226502277 date "2022-01-01" @default.
• W4226502277 modified "2023-10-18" @default.
• W4226502277 title "Anti-Angiogenic and Anti-Metastatic Effects of Biogenic Silver Nanoparticles Synthesized Using &lt;i&gt;Azadirachta indica&lt;/i&gt;" @default.
• W4226502277 cites W1038585844 @default.
• W4226502277 cites W1486351830 @default.
• W4226502277 cites W1505632988 @default.
• W4226502277 cites W1523347226 @default.
• W4226502277 cites W1623624356 @default.
• W4226502277 cites W1968154498 @default.
• W4226502277 cites W1985801265 @default.
• W4226502277 cites W2014920011 @default.
• W4226502277 cites W2054874597 @default.
• W4226502277 cites W2060340186 @default.
• W4226502277 cites W2086775675 @default.
• W4226502277 cites W2118408607 @default.
• W4226502277 cites W2133028090 @default.
• W4226502277 cites W2165575224 @default.
• W4226502277 cites W2167265152 @default.
• W4226502277 cites W2255518001 @default.
• W4226502277 cites W2292835564 @default.
• W4226502277 cites W2395365859 @default.
• W4226502277 cites W2402794364 @default.
• W4226502277 cites W2495932021 @default.
• W4226502277 cites W2774960489 @default.
• W4226502277 cites W2783104989 @default.
• W4226502277 cites W2897356787 @default.
• W4226502277 cites W2912378464 @default.
• W4226502277 cites W2913789563 @default.
• W4226502277 cites W2935538420 @default.
• W4226502277 cites W2961643325 @default.
• W4226502277 cites W2972713173 @default.
• W4226502277 cites W3010044113 @default.
• W4226502277 cites W3034187300 @default.
• W4226502277 cites W3135119239 @default.
• W4226502277 cites W3135906711 @default.
• W4226502277 cites W3136823837 @default.
• W4226502277 cites W3158453489 @default.
• W4226502277 cites W3208627973 @default.
• W4226502277 cites W335253295 @default.
• W4226502277 cites W4285103361 @default.
• W4226502277 doi "https://doi.org/10.4236/abb.2022.134010" @default.
• W4226502277 hasPublicationYear "2022" @default.
• W4226502277 type Work @default.
• W4226502277 citedByCount "14" @default.
• W4226502277 countsByYear W42265022772022 @default.
• W4226502277 countsByYear W42265022772023 @default.
• W4226502277 crossrefType "journal-article" @default.
• W4226502277 hasAuthorship W4226502277A5000715076 @default.
• W4226502277 hasAuthorship W4226502277A5016973739 @default.
• W4226502277 hasAuthorship W4226502277A5041280072 @default.
• W4226502277 hasAuthorship W4226502277A5050446365 @default.
• W4226502277 hasAuthorship W4226502277A5057461703 @default.
• W4226502277 hasAuthorship W4226502277A5070791069 @default.
• W4226502277 hasAuthorship W4226502277A5074017276 @default.
• W4226502277 hasAuthorship W4226502277A5082515443 @default.
• W4226502277 hasBestOaLocation W42265022771 @default.
• W4226502277 hasConcept C121608353 @default.
• W4226502277 hasConcept C126322002 @default.
• W4226502277 hasConcept C142724271 @default.
• W4226502277 hasConcept C155672457 @default.
• W4226502277 hasConcept C16685009 @default.
• W4226502277 hasConcept C171250308 @default.
• W4226502277 hasConcept C185592680 @default.
• W4226502277 hasConcept C192562407 @default.
• W4226502277 hasConcept C25642318 @default.
• W4226502277 hasConcept C2776438761 @default.
• W4226502277 hasConcept C2779013556 @default.
• W4226502277 hasConcept C2779723316 @default.
• W4226502277 hasConcept C2780394083 @default.
• W4226502277 hasConcept C2781035296 @default.
• W4226502277 hasConcept C31499863 @default.
• W4226502277 hasConcept C502942594 @default.
• W4226502277 hasConcept C55493867 @default.
• W4226502277 hasConcept C556039675 @default.
• W4226502277 hasConcept C71924100 @default.
• W4226502277 hasConcept C86803240 @default.
• W4226502277 hasConcept C96232424 @default.
• W4226502277 hasConcept C97230052 @default.
• W4226502277 hasConcept C98274493 @default.
• W4226502277 hasConceptScore W4226502277C121608353 @default.
• W4226502277 hasConceptScore W4226502277C126322002 @default.
• W4226502277 hasConceptScore W4226502277C142724271 @default.
• W4226502277 hasConceptScore W4226502277C155672457 @default.
• W4226502277 hasConceptScore W4226502277C16685009 @default.
• W4226502277 hasConceptScore W4226502277C171250308 @default.
• W4226502277 hasConceptScore W4226502277C185592680 @default.
• W4226502277 hasConceptScore W4226502277C192562407 @default.
• W4226502277 hasConceptScore W4226502277C25642318 @default.

• next